Press Releases
14 hours ago
Zealand Pharma conference call on February 19 at 2pm CET (8am ET) to present full year 2025 financial results
Indeterminate
GlobeNewswire, Inc.
15 hours ago
Spring 2026 Pre-Conference Healthcare Benefits Symposium Equips CFOs to Tackle Rising Benefit Costs
Neutral
EIN Presswire
17 hours ago
Corbus Pharmaceuticals to Present at the 36th Annual Oppenheimer Healthcare Life Sciences Conference
Indeterminate
GlobeNewswire, Inc.
17 hours ago
ORYZON Announces Appointment of Rolando Gutierrez-Esteinou, M.D., as Chief Medical Officer for CNS
Indeterminate
GlobeNewswire, Inc.
18 hours ago
Ampersand Capital Partners Acquires Purna Pharmaceuticals
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
Medical Device Contract Manufacturing Set to Reach $155.2 Billion Globally by 2030
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
CalMHSA Selects Eleos as Statewide AI Technology Partner for Behavioral Health
Indeterminate
GlobeNewswire, Inc.
Feb. 11, 2026
Clairity Founder and CEO, Dr. Connie Lehman, Named to TIME’s 2026 TIME100 Health List
Indeterminate
GlobeNewswire, Inc.
Feb. 10, 2026
Health Officials Investigating Measles Exposures to DC Residents
Gov't Institution
District of Columbia Health
Owner: American Government
Feb. 10, 2026
Helus Pharma Appoints Michael Cola as Chief Executive Officer to Lead Next Phase of Scale and Execution
Indeterminate
GlobeNewswire, Inc.
Feb. 10, 2026
Active Implantable Medical Devices Market Forecast to Reach USD 39.44 Billion by 2034
Neutral
EIN Presswire
Feb. 10, 2026
OKYO Pharma Strengthens World Class Leadership Team with Appointment of Flavio Mantelli, MD, PhD as Chief Medical Officer
Indeterminate
GlobeNewswire, Inc.
Feb. 10, 2026
Shatz, Schwartz and Fentin attorneys publish authoritative guide to Massachusetts Elder Law
Neutral
EIN Presswire
Feb. 8, 2026
Health Officials Investigating Measles Exposures to DC Residents
Gov't Institution
District of Columbia Health
Owner: American Government